EASD 2025 15 - 19 September 2025

Effect of semaglutide on the initiation of additional glucose-lowering therapy: An analysis of the SELECT trial

Authors :

Steven E Kahn¹; Ole Kleist Jeppesen²; A Michael Lincoff³; Ildiko Lingvay⁴; Jorge Plutzky⁵; Anders Rasmussen Rinnov²; Donna H Ryan⁶; Scott S Emerson⁷

Affiliations

View Details Hide Details

{{ getPageNum(PDFPage) }}

Keywords

Cardiovascular Disease

Congress short oral presentation

GLP-1 RA

Semaglutide

PHASE 3 (RCT)